S'abonner

A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment - 11/11/23

Doi : 10.1016/j.biopha.2023.115831 
Mingtai Chen a, b, 1, Furong Huang a, 1, Bohao Chen c, 1, Junli Kang a, 1, Yijing Yao a, 1, Mengnan Liu d, 1, Yuanyuan Li a, 1, Yaqin Li a, e, Tianran Zhou b, Deti Peng b, Lidan Luo b, Chunshan Wei b, Yufeng Xing b, Qibiao Wu a, , Hua Zhou f, , Guangdong Tong a, b, c,
a Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau 
b Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, PR China 
c Shenzhen Traditional Chinese Medicine Hospital, Nanjing University of Chinese Medicine, Shenzhen, PR China 
d National Traditional Chinese Medicine Clinical Research Base and Department of Cardiovascular Medicine, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, PR China 
e Department of Infectious Disease, Peking University Shenzhen Hospital, PR China 
f Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, PR China 

Correspondence to: Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau.Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and TechnologyAvenida Wai LongTaipaMacau⁎⁎Correspondence to: Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, No. 55, Neihuan West Road, University Town, Panyu District, Guangzhou, Guangdong, PR China.Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease ResearchNo. 55, Neihuan West Road, University Town, Panyu DistrictGuangzhouGuangdongPR China⁎⁎⁎Correspondence to: Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, No.1 Fuhua Road, Futian District, Shenzhen, Guangdong, PR China.Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese MedicineNo.1 Fuhua Road, Futian DistrictShenzhenGuangdongPR China

Abstract

Background

Nonalcoholic steatohepatitis (NASH) has caused a significant burden on public health care systems, the economy and society. However, there has still been no officially approved pharmacotherapy for NASH. It has been suggested that oxidative stress and mitochondrial dysfunction play vital roles in NASH pathological progression. Shugan Xiaozhi (SG) formula, as a kind of classical herbal formula, was shown to attenuate NASH.

Purpose

This study aimed to explore the potential mechanisms of SG formula treating NASH.

Study design and methods

Ultra-high-performance liquid chromatography-high resolution mass spectrometry combined with bioinformatics analysis was applied to explore the therapeutic targets and main components of SG formula. Moreover, in vivo NASH model was utilized to confirmed the therapeutic effects of SG formula. Molecular docking analysis and further validation experiments were conducted to verify the results of bioinformatics analysis.

Results

The in vivo experiments confirmed SG formula significantly attenuated hepatic pathological progression and relieved oxidative stress in high-fat diet (HFD) induced - NASH model. Ultra-high-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) combined with bioinformatics analysis expounded the components of SG formula and revealed the mitochondrial regulation mechanism of SG formula treating NASH. Further in vivo experiments validated that SG formula could alleviate oxidative stress by rehabilitating the structure and function of mitochondria, which was strongly related to regulating mitophagy.

Conclusion

In summary, this study demonstrated that SG formula, which could attenuate NASH by regulating mitochondria and might be a potential pharmacotherapy for NASH.

Le texte complet de cet article est disponible en PDF.

Highlights

In vivo experiments demonstrated that SG formula could improve the serum levels of AST, ALT, TNF-α, and IL-6, reduce the serum levels of TC and TG, and attenuate hepatic steatosis, lobular inflammation, hepatocellular ballooning and fibrosis in HFD-induced NASH model mice.
Ultra-high-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) identified 41 components of SG formula.
The results of network pharmacology analysis revealed the mitochondrial regulation mechanism of SG formula treating NASH.
Further experiment validated that the therapeutic effect of SG formula on NASH was strongly related to regulating BNIP3/BNIP3L mediated mitophagy.

Le texte complet de cet article est disponible en PDF.

Abbreviations : ALT, AP, ASS, AST, BS, CAP, CAT, CE, CH, DDA, DH, ESI, FL, GC, GO, GSH, H&E, HCD, HFD, HFS, HY, IL-6, JMZ, KEGG, LC3, MDA, NAFL, NAFLD, NASH, NASH, NWA, p62, PB, PDB, PPI, PVDF, ROS, SG, SOD, SZ, TC, CHM, TEM, TG, TNF-α, TR, UPLC-HRMS, YC, ZL, ZS, ZX, ZZ

Keywords : Herbal medicine, Nonalcoholic steatohepatitis, Mitochondria, Bioinformatics analysis, UPLC-HRMS


Plan


© 2023  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 168

Article 115831- décembre 2023 Retour au numéro
Article précédent Article précédent
  • Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
  • Aussara Panya, Chutamas Thepmalee, Nunghathai Sawasdee, Sasithorn Saengmuang, Piriya Luangwattananun, Pa-thai Yenchitsomanus
| Article suivant Article suivant
  • Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation
  • Jinxiao Li, Luorui Shang, Fangyuan Zhou, Shuhan Wang, Na Liu, Minfeng Zhou, Qifeng Lin, Mengqi Zhang, Yuju Cai, Guo Chen, Shenglan Yang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.